NCT03960801View on ClinicalTrials.gov

Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant

PHASE3CompletedINTERVENTIONAL
Enrollment

1,150

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

April 22, 2021

Study Completion Date

April 22, 2021

Conditions
Intra-tracheal Intubation
Interventions
DRUG

Remifentanil group

bolus intravenous injection of 3 to 4µg/kg of remifentanil after hypnotic administration for a crush anesthetic induction

DRUG

neuromuscular blockade group

Bolus intravenous injection of 1mg/kg of Succinylcholine or Rocuronium after hypnotic administration for a crush anesthetic induction

Trial Locations (13)

Unknown

University Hospital, Angers

Military Hospital, Brest

University Hospital, Brest

University Hospital, Grenoble

CHD Vendée, La Roche-sur-Yon

Hospital, Le Mans

University hospital (SALENGRO hospital), Lille

University Hospital, Lille

University Hospital Lyon Sud, Lyon

Le Confluent, Nantes

University Hospital, Nantes

Toulouse University Hospital, Toulouse

Hospital, Valenciennes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03960801 - Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant | Biotech Hunter | Biotech Hunter